| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,260 |
1,213 |
$131K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,138 |
2,098 |
$122K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,153 |
1,837 |
$70K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
525 |
524 |
$45K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
477 |
476 |
$41K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
318 |
318 |
$30K |
| 90461 |
|
592 |
579 |
$22K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,105 |
2,104 |
$19K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
236 |
233 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,650 |
1,610 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
343 |
342 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
213 |
212 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
401 |
389 |
$14K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
464 |
458 |
$11K |
| 99051 |
|
364 |
363 |
$6K |
| 96127 |
|
579 |
579 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
174 |
172 |
$5K |
| 99173 |
|
115 |
115 |
$3K |
| 92587 |
|
100 |
100 |
$2K |
| 85018 |
|
698 |
698 |
$1K |
| 81003 |
|
684 |
677 |
$1K |
| 83655 |
|
107 |
107 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
80 |
80 |
$976.80 |
| 83718 |
|
105 |
105 |
$778.64 |
| 82465 |
|
105 |
105 |
$413.47 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$245.40 |
| 92551 |
|
14 |
14 |
$118.02 |